6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
Just now	Amerigo Resources Announces Successful Completion of MVC Supervisors' Union Negotiation
Just now	Galleon Gold's 2026 Drilling Confirms Down-Dip Continuity at Zone #9 and Expands South Zone Footprint
Just now	Scorpio Gold Drills 2.68 g/t Gold over 11.34 Metres from Surface Along the Zanzibar Trend, at Manhattan, Nevada
10m ago	Oil and Gas Development : OGDC Secures Eight Offshore Blocks in Bid Round 2025
12m ago	NN N : Presentation annual general meeting NN Group N.V. 2026 (nn group presentation agm 2026)

About

4.76USD+0.21 +4.62%

Closed • Updated at 12:00 GMT+00:00

Market Cap$141.79M

Volume34.4K

Beta0.00

RSI72.75

Health TechnologyPharmaceuticals: Major

Turn Therapeutics Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Turn Therapeutics Appoints Physician-Scientist and Former FDA Commissioner, Dr. Stephen M. Hahn, as Executive Clinical and Regulatory Lead

Turn Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Turn Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates

Turn Therapeutics Secures Up to $25 Million in Financing From Avenue Capital Group

Turn Therapeutics Appoints Dr. Robert Redfield as Senior Advisor of Health Policy and Regulatory Affairs

Community Chat

Ask AI